Carly Thompson
Family · Grand Rapids, MINPI 1700492683
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 252 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 252 payments — averaging $19.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$797
- Pfizer$470
- AbbVie$386
- Amgen$342
- Lilly USA, LLC$323
- AstraZeneca$306
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,92998%
- Other$792%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 44 | $797 |
| Pfizer | 24 | $470 |
| AbbVie | 20 | $386 |
| Amgen | 18 | $342 |
| Lilly USA, LLC | 18 | $323 |
| AstraZeneca | 19 | $306 |
| Astellas Pharma US Inc | 10 | $294 |
| Teva Pharmaceuticals USA, Inc. | 15 | $286 |
| Biohaven Pharmaceutical Holding Company Ltd. | 15 | $255 |
| Lundbeck LLC | 10 | $254 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $205 |
| Axsome Therapeutics, Inc. | 5 | $137 |
| Neurocrine Biosciences, Inc. | 5 | $125 |
| Biohaven Pharmaceuticals, Inc. | 6 | $112 |
| Collegium Pharmaceutical, Inc. | 4 | $69 |
| Eisai Inc. | 2 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Novartis | 3 | $59 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
| Exact Sciences | 2 | $48 |
| Alkermes, Inc. | 2 | $47 |
| Biogen | 2 | $44 |
| Baxter Healthcare | 1 | $40 |
| Welch Allyn | 1 | $40 |
| Cranial Technologies, Inc | 2 | $38 |
| Harmony Biosciences LLC | 1 | $38 |
| Phadia US Inc. | 2 | $35 |
| Johnson & Johnson | 1 | $28 |
| Verona Pharma, Inc. | 1 | $25 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$125
How this compares
$5,009 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,132 |
| Levothyroxine Sodium | 14 | $259 |
Paid to pharmacies, not to this prescriber.
Other family in Grand Rapids
- Kelsey PrinceGrand Rapids$87K
- Marlee BogemaGrand Rapids$15K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.